open mobile menu

Accelerate Time-To-Market With a Proven Team of GI Experts

Tap into our extensive network of 5,000+ sites, leveraging exclusive data from central imaging projects in endoscopy and histopathology, and benefit from our team of medical and operational GI experts for swift study startup and accelerated patient recruitment.
5,000+ sites in more than 60 countries
Supporting >70% of IBD compounds currently in development
Unrivaled KOL network

Therapeutic Focus

Alimentiv stands at the forefront of patient recruitment and imaging innovations for gastrointestinal and liver diseases, driving health breakthroughs through advanced research, accelerated clinical trials, and delivering actionable biomarker insights. We are dedicated to redefining the future of GI and liver clinical research.

IBD
EGID/EoE
Celiac
Hepatology

Services

With over 30 years of pioneering advancements in gastrointestinal therapeutics, Alimentiv continues to advance clinical trials through medical research, development, and imaging solutions. Our team offers streamlined solutions for all stages of clinical development, from early phase 1 to phase 4 trials.

Clinical Trial Services
Medical Imaging Solutions
Precision Medicine
Medical Research & Development
Statistics
Real-World Evidence
Specialty Histopathology Lab
Spatial Biology

Latest Updates

Brochure Mar 20, 2025
Clinical Trial Services

In the complex world of gastroenterology (GI) clinical trials, you need a partner who understands the challenges of running global GI studies....

Publication Feb 28, 2025
Placebo Rates in Crohn’s Disease Randomized Clinical Trials: An Individual Patient Data Meta-Analysis

Brian Feagan, Christopher Ma, Guangyong Zou, Malcolm Hogan, Vipul Jairath

News Feb 11, 2025
Alimentiv to Present Key Insights Into GI Research With Multiple Presentations and Posters at the 20th ECCO Congress

February 12, 2025 – Alimentiv Inc. (“Alimentiv”) is pleased to announce multiple presentations and posters at the 20th Congress of ECCO (European Crohn’s and Colitis...

See All Updates

Speak to a member
of our expert team

Contact us